Patrick J Smith1, James A Blumenthal2, Alan L Hinderliter3, Lana L Watkins2, Benson M Hoffman2, Andrew Sherwood2. 1. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC. Electronic address: patrick.j.smith@dm.duke.edu. 2. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC. 3. Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Abstract
BACKGROUND: Cardiovascular risk factors (CVRFs) and endothelial dysfunction have been associated independently with poorer neurocognition in middle-aged adults, particularly on tests of frontal lobe function. However, to our knowledge, no studies have examined markers of microvascular dysfunction on neurocognition or the potential interaction between macro- and microvascular biomarkers on neurocognition in middle-aged and older adults with major depressive disorder (MDD). METHODS: Participants included 202 adults with MDD who were not receiving mental health treatment. Microvascular endothelial function was assessed using a noninvasive marker of forearm reactive hyperemia velocity while macrovascular endothelial function was assessed using flow-mediated dilation (FMD) of the brachial artery. CVRFs were assessed using the Framingham Stroke Risk Profile and fasting lipid levels. A standardized neurocognitive assessment battery was used to assess three cognitive domains: executive function, working memory, and verbal memory. RESULTS: Greater microvascular dysfunction was associated with poorer neurocognition across all three domains. Microvascular function continued to predict verbal memory performance after accounting for background factors and CVRFs. Macro- and microvascular function interacted to predict working memory performance (F = 4.511, 178, p = 0.035), with a similar nonsignificant association for executive function (F = 2.731, 178, p = 0.095), with moderate associations observed between microvascular function and neurocognition in the presence of preserved FMD (r61 = 0.40, p = 0.001), but not when FMD was impaired (r63 = -0.05, p = 0.675). CONCLUSION: Greater microvascular dysfunction is associated with poorer neurocognition among middle-aged and older adults. This association was strongest in participants with preserved macrovascular function.
BACKGROUND: Cardiovascular risk factors (CVRFs) and endothelial dysfunction have been associated independently with poorer neurocognition in middle-aged adults, particularly on tests of frontal lobe function. However, to our knowledge, no studies have examined markers of microvascular dysfunction on neurocognition or the potential interaction between macro- and microvascular biomarkers on neurocognition in middle-aged and older adults with major depressive disorder (MDD). METHODS:Participants included 202 adults with MDD who were not receiving mental health treatment. Microvascular endothelial function was assessed using a noninvasive marker of forearm reactive hyperemia velocity while macrovascular endothelial function was assessed using flow-mediated dilation (FMD) of the brachial artery. CVRFs were assessed using the Framingham Stroke Risk Profile and fasting lipid levels. A standardized neurocognitive assessment battery was used to assess three cognitive domains: executive function, working memory, and verbal memory. RESULTS: Greater microvascular dysfunction was associated with poorer neurocognition across all three domains. Microvascular function continued to predict verbal memory performance after accounting for background factors and CVRFs. Macro- and microvascular function interacted to predict working memory performance (F = 4.511, 178, p = 0.035), with a similar nonsignificant association for executive function (F = 2.731, 178, p = 0.095), with moderate associations observed between microvascular function and neurocognition in the presence of preserved FMD (r61 = 0.40, p = 0.001), but not when FMD was impaired (r63 = -0.05, p = 0.675). CONCLUSION: Greater microvascular dysfunction is associated with poorer neurocognition among middle-aged and older adults. This association was strongest in participants with preserved macrovascular function.
Authors: Karin F Hoth; David F Tate; Athena Poppas; Daniel E Forman; John Gunstad; David J Moser; Robert H Paul; Angela L Jefferson; Andreana P Haley; Ronald A Cohen Journal: Stroke Date: 2007-01-04 Impact factor: 7.914
Authors: Ronald A Cohen; Athena Poppas; Daniel E Forman; Karin F Hoth; Andreana P Haley; John Gunstad; Angela L Jefferson; David F Tate; Robert H Paul; Lawrence H Sweet; Mokato Ono; Beth A Jerskey; Marie Gerhard-Herman Journal: J Clin Exp Neuropsychol Date: 2008-06-16 Impact factor: 2.475
Authors: Rufus O Akinyemi; Elizabeta B Mukaetova-Ladinska; Johannes Attems; Masafumi Ihara; Raj N Kalaria Journal: Curr Alzheimer Res Date: 2013-07 Impact factor: 3.498
Authors: D Consoli; A Di Carlo; D Inzitari; D De Lucia; M Lamassa; M D'Avino; M Baldereschi; M Muto; A Mandarino; M Napolitano; M F Romano; D Caruso Journal: Eur J Neurol Date: 2007-09-14 Impact factor: 6.089
Authors: Jacobus F A Jansen; Frank C G van Bussel; Harm J van de Haar; Matthias J P van Osch; Paul A M Hofman; Martin P J van Boxtel; Robert J van Oostenbrugge; Miranda T Schram; Coen D A Stehouwer; Joachim E Wildberger; Walter H Backes Journal: Sci Rep Date: 2016-12-05 Impact factor: 4.379
Authors: Dae Hyun Kim; Francine Grodstein; Anne B Newman; Paulo H M Chaves; Michelle C Odden; Ronald Klein; Mark J Sarnak; Lewis A Lipsitz Journal: J Am Geriatr Soc Date: 2015-09-04 Impact factor: 5.562
Authors: Patrick J Smith; James A Blumenthal; Alan L Hinderliter; Stephanie M Mabe; Jeanne E Schwartz; Forgive Avorgbedor; Andrew Sherwood Journal: J Hypertens Date: 2019-05 Impact factor: 4.844
Authors: Patrick J Smith; Andrew Sherwood; Alan L Hinderliter; Stephanie Mabe; Lana L Watkins; Linda Craighead; Krista Ingle; Crystal Tyson; Forgive Avorgbedor; Pao-Hwa Lin; William E Kraus; Lawrence Liao; James A Blumenthal Journal: J Hypertens Date: 2022-06-10 Impact factor: 4.776
Authors: R A O'Neill; A P Maxwell; F Kee; I Young; R E Hogg; S Cruise; B McGuinness; G J McKay Journal: BMC Geriatr Date: 2021-01-15 Impact factor: 3.921
Authors: Deborah M Oyeyemi; Mary Cooter; Stacey Chung; Heather E Whitson; Jeffrey N Browndyke; Michael J Devinney; Patrick J Smith; Grant E Garrigues; Eugene Moretti; Judd W Moul; Harvey Jay Cohen; Joseph P Mathew; Miles Berger Journal: J Geriatr Psychiatry Neurol Date: 2020-12-30 Impact factor: 2.680